Journals / Turkish Thoracic Journal / 2019 / Cilt: 20 - Sayı: 4

Serum Albumin as a Biomarker of Pulmonary Sarcoidosis Chronicity

Pages
236–240
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A receiver operating characteristics curve analysis for prediction of sarcoidosis of a >10 yearsduration gave an area under curve (AUC) of 0.722 (95% CI 0.620–0.824, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: The duration of sarcoidosis is associated with a higher risk of irreversible pulmonary fibrosis.
📊
Key Findings & Data:Biomarkers of sarcoidosis durationhave not been previously explored.MATERIALS AND METHODS: A retrospective study was conducted to investigate independent biomarkers of pulmonary sarcoidosisduration.RESULTS: A total of 108 cases with pulmonary sarcoidosis (mean age 53.4 years; 76.9% females; average duration of sarcoidosis 12years) were included in the study.
💡
Conclusion & Impact:A receiver operating characteristics curve analysis for prediction of sarcoidosis of a >10 yearsduration gave an area under curve (AUC) of 0.722 (95% CI 0.620–0.824, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVES: The duration of sarcoidosis is associated with a higher risk of irreversible pulmonary fibrosis. Sarcoidosis shows diverseclinical presentations, which may lead to a delayed diagnosis due to lack of a specific diagnostic test. Biomarkers of sarcoidosis durationhave not been previously explored.MATERIALS AND METHODS: A retrospective study was conducted to investigate independent biomarkers of pulmonary sarcoidosisduration.RESULTS: A total of 108 cases with pulmonary sarcoidosis (mean age 53.4 years; 76.9% females; average duration of sarcoidosis 12years) were included in the study. We found significant correlation between the duration of sarcoidosis and serum albumin levels(r=−0.414, p=0.0001), sedimentation rate (r=0.375, p=0.001), pulmonary artery systolic pressure (r= 0.468, p=0.003), diffusion capacity (r=−0.334, p=0.002), and age (r=0.492, p=0.0001). A multivariate linear regression analysis revealed that serum albumin levels(β=−5.242, 95% confidence interval [CI] −8.372 to −2.112, p=0.001) and age (β=0.367, 95% CI 0.164 to 0.570, p=0.001) were independent correlates of sarcoidosis duration. A receiver operating characteristics curve analysis for prediction of sarcoidosis of a >10 yearsduration gave an area under curve (AUC) of 0.722 (95% CI 0.620–0.824, p

🔖

Cite This Article

Isma, S. J., Omar, H. R., Sweiss, N., Mirsaeidi, M. (2022). Serum Albumin as a Biomarker of Pulmonary Sarcoidosis Chronicity. Turkish Thoracic Journal, Cilt: 20 - Sayı: 4, 236–240. https://ajindex.com/articles/618115

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55
  2. Costabel U. Sarcoidosis: clinical update. Eur Respir J Suppl 2001;32:56s-68s
  3. Wu JJ, Schiff KR. Sarcoidosis. Am Fam Physician 2004;70:312- 22
  4. Newman LS, Rose CS, Maier LA. Sarcoidosis. N England J Med 1997;336:1224-34. [CrossRef] 5. Rybicki BA, Major M, Popovich Jr J, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-41. [CrossRef] 6. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885-9. [CrossRef] 7. Culver DA, Thomassen M, Kavuru MS. Pulmonary sarcoidosis: new genetic clues and ongoing treatment controversies. Cleve Clin J Med 2004;71:88. [CrossRef] 8. Ishida S, Hashimoto I, Seike T, et al. Serum albumin levels correlate with inflammation rather than nutrition supply in burns patients: a retrospective study. J Med Invest 2014;61:361-8. [CrossRef] 9. Franch-Arcas G. The meaning of hypoalbuminaemia in clinical practice. Clin Nutr 2001;20:265-9. [CrossRef] 10. Lyons O, Whelan B, Bennett K, et al. Serum albumin as an outcome predictor in hospital emergency medical admissions. Eur J Intern Med 2010;21:17-20. [CrossRef] 11. Mirsaeidi M, Omar HR, Sweiss N. Hypoalbuminemia is related to inflammation rather than malnutrition in sarcoidosis. Eur J Intern Med 2018;53:e14-e6. [CrossRef] 12. Neville E, Walker A, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983;52:525-33
  5. Rothkrantz-Kos S1, van Dieijen-Visser MP, Mulder PG, et al. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem 2003;49:1510-7. [CrossRef] 14. Shorr AF, Murphy FT, Gilliland WR, et al. Osseous disease in patients with pulmonary sarcoidosis and musculoskeletal symptoms. Respir Med 2000;94:228-32. [CrossRef]